Positron emission tomography for predicting recurrence in stage I lung adenocarcinoma: Standardized uptake value corrected by mean liver standardized uptake value

European Journal of Cardio-thoracic Surgery

Volumn 40, Issue 5, 2011, Pages 1165-1169

  Shiono, Satoshi ^a   Abiko, Masami ^a   Okazaki, Toshimasa ^a   Chiba, Masato ^a   Yabuki, Hiroshi ^a   Sato, Toru ^a  

^a Yamagata Prefectural Central Hospital   (Japan)

Author keywords

Lung cancer; PET CT; Stage i; SUV

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CALCULATION; CANCER RECURRENCE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE FREE SURVIVAL; DISEASE MARKER; FEMALE; HISTOPATHOLOGY; HUMAN; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALIDITY; PRIORITY JOURNAL; REPRODUCIBILITY; RISK FACTOR; SEX DIFFERENCE; SMOKING; STANDARDIZATION; STANDARDIZED UPTAKE VALUE; STATISTICAL SIGNIFICANCE; UNIVARIATE ANALYSIS;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; LIVER; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROGNOSIS;

EID: 80053985143     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1016/j.ejcts.2011.02.041     Document Type: Article

References (25)

1. Berghmans T., Dusart M., Paesmans M., Hossein-Foucher C., Buvat I., Castaigne C., Scherpereel A., Mascaux C., Moreau M., Roelandts M., Alard S., Meert A.P., Patz E.F., Lafitte J.J., Sculier J.P. Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC). A systematic review and meta-analysis (MA) by the European lung cancer working party for the IASLC lung cancer staging project. J Thorac Oncol 2008, 3:6-12. European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project.
2. Paesmans M., Berghmans T., Dusart M., Garcia C., Hossein-Foucher C., Lafitte J.J., Mascaux C., Meert A.P., Roelandts M., Scherpereel A., Terrones Munoz V., Sculier J.P. Primary tumor standardized uptake value measured on fluorodeoxyglucose positron emission tomography is of prognostic value for survival in non-small cell lung cancer. Update of a systematic review and meta-analysis by the European lung cancer working party for the international association for the study of lung cancer staging project. J Thorac Oncol 2010, 5:612-619. European Lung Cancer Working Party, on behalf of the IASLC Lung Cancer Staging Project.
3. Erasmus J.J., Rohren E., Swisher S.G. Prognosis and reevaluation of lung cancer by positron emission tomography imaging. Proc Am Thorac Soc 2009, 6:171-179.
4. Higashi K., Ueda Y., Arisaka Y., Sakuma T., Nambu Y., Oguchi M., Seki H., Taki S., Tonami H., Yamamoto I. 18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer. J Nucl Med 2002, 43:39-45.
5. Downey R.J., Akhurst T., Gonen M., Vincent A., Bains M.S., Larson S., Rusch V. Preoperative F-18 Fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection. J Clin Oncol 2004, 22:3255-3260.
6. Cerfolio R.J., Bryant A.S., Ohja B., Bartolucci A.A. The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival. J Thorac Cardiovasc Surg 2005, 130:151-159.
7. Sasaki R., Komaki R., Macapinlac H., Erasmus J., Allen P., Forster K., Putnam J.B., Herbst R.S., Moran C.A., Podoloff D.A., Roth J.A., Cox J.D. [18F]Fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer. J Clin Oncol 2005, 23:1136-1143.
8. Al-Sarraf N., Gately K., Lucey J., Aziz R., Doddakula K., Wilson L., McGovern E., Young V. Clinical implication and significance of standardized uptake value of primary non-small cell lung cancer on positron emission tomography: analysis of 176 cases. Eur J Cardiothorac Surg 2008, 34:892-897.
9. Goodgame B., Pillot G.A., Yang Z., Shriki J., Meyers B.F., Zoole J., Gao F., Dehdashti F., Patterson A., Siegel B.A., Govindan R. Prognostic value of preoperative positron emission tomography in resected stage I non-small cell lung cancer. J Thorac Oncol 2008, 3:130-134.
10. Ohtsuka T., Nomori H., Watanabe K., Kaji M., Naruke T., Suemasu K., Uno K. Prognostic significance of [18F]fluorodeoxyglucose uptake on positron emission tomography in patients with pathologic stage I lung adenocarcinoma. Cancer 2006, 107:2468-2473.
11. Um S.W., Kim H., Koh W.J., Suh G.Y., Chung M.P., Kwon O.J., Choi J.Y., Han J., Lee K.S., Kim J. Prognostic value of 18F-FDG uptake on positron emission tomography in patients with pathologic stage I non-small cell lung cancer. J Thorac Oncol 2009, 4:1331-1336.
12. Okada M., Tauchi S., Iwanaga K., Mimura T., Kitamura Y., Watanabe H., Adachi S., Sakuma T., Ohbayashi C. Associations among bronchioloalveolar carcinoma components, positron emission tomographic and computed tomographic findings, and malignant behavior in small lung adenocarcinomas. J Thorac Cardiovasc Surg 2007, 133:1448-1454.
13. Hanin F.X., Lonneux M., Cornet J., Noirhomme P., Coulon C., Distexhe J., Poncelet A.J. Prognostic value of FDG uptake in early stage non-small cell lung cancer. Eur J Cardiothorac Surg 2008, 33:819-823.
14. Nair V.S., Barnett P.G., Ananth L., Gould M.K. Positron emission tomography (PET) 18F-fluorodeoxyglucose (FDG) uptake and prognosis in patients with resected, clinical stage IA non-small cell lung cancer. Chest 2010, 137:1150-1156. Veterans Affairs Solitary Nodule Accuracy Project Cooperative Studies Group.
15. Shiono S., Abiko M., Sato T. Positron emission tomography/computed tomography and lymphovascular invasion predict recurrence in stage I lung cancers. J Thorac Oncol 2011, 6:43-47.
16. Goldstraw P., Crowley J., Chansky K., Giroux D.J., Groome P.A., Rami-Porta R., Postmus P.E., Rusch V., Sobin L. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007, 2:706-714. International Association for the Study of Lung Cancer International Staging Committee; Participating Institutions.
17. Boellaard R. Standards for PET image acquisition and quantitative data analysis. J Nucl Med 2009, 50:11S-20S.
18. Paquet N., Albert A., Foidart J., Hustinx R. Within-patient variability of 18F-FDG: standardized uptake values in normal tissue. J Nucl Med 2004, 45:784-788.
19. Kamibayashi T., Tsuchida T., Demura Y., Tsujikawa T., Okazawa H., Kudoh T., Kimura H. Reproducibility of semi-quantitative parameters in FDG-PET using two different PET scanners: Influence of attenuation correction method and examination interval. Mol Imaging Biol 2008, 10:162-166.
20. Mandrekar J.N. Receiver operating characteristic curve in diagnostic test assessment. J Thorac Oncol 2010, 5:1315-1316.
21. Youden W.J. Index for rating diagnostic tests. Cancer 1950, 3:32-35.
22. Nakayama H., Okumura S., Daisaki H., Kato Y., Uehara H., Adachi S., Yoshimura M., Okada M. Value of integrated positron emission tomography revised using a phantom study to evaluate malignancy grade of lung adenocarcinoma. A multicenter study. Cancer 2010, 116:3170-3177.
23. Westerterp M., Pruim J., Oyen W., Hoekstra O., Paans A., Visser E., van Lanschot J., Sloof G., Boellaard R. Quantification of FDG PET studies using standardized uptake values in multi-center trials: effects of image reconstruction, resolution and ROI definition parameters. Eur J Nucl Med Mol Imaging 2007, 34:392-404.
24. Ohba Y., Nomori H., Shibata H., Kobayashi H., Mori T., Shiraishi S., Nakashima R. Evaluation of semiquantitative assessments of fluorodeoxyglucose uptake on positron emission tomography scans for the diagnosis of pulmonary malignancies 1 to 3cm in size. Ann Thorac Surg 2009, 87:886-892.
25. Dooms C., Vansteenkiste J. Prognostic value of fluorodeoxyglucose uptake in non-small cell lung cancer: time for standardization and validation. J Thorac Oncol 2010, 5:583-584.